Michael R. Grunwald

3.9k total citations
90 papers, 1.5k citations indexed

About

Michael R. Grunwald is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Michael R. Grunwald has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 41 papers in Genetics and 24 papers in Molecular Biology. Recurrent topics in Michael R. Grunwald's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Acute Myeloid Leukemia Research (33 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Michael R. Grunwald is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Acute Myeloid Leukemia Research (33 papers) and Chronic Myeloid Leukemia Treatments (17 papers). Michael R. Grunwald collaborates with scholars based in United States, Canada and United Kingdom. Michael R. Grunwald's co-authors include Mark J. Levis, Lawrence V. Hofmann, Luis A. Díaz, Lynn Howie, Rebecca Dezube, Hsin‐Chieh Yeh, Rakhi P. Naik, Naresh M. Punjabi, Joseph Cofrancesco and Sanjay V. Desai and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Michael R. Grunwald

77 papers receiving 1.5k citations

Peers

Michael R. Grunwald

HEMAT

GENET

ONCOL

PHEOH

Maria Caterina Putti Italy

Hiroto Narimatsu Japan

Rahma Warsame United States

A O’Farrell Ireland

Beth Faiman United States

Oumar Sy United States

Bernward Zeller Norway

Sarah Buckley United States

Susan Wright Australia

Shiann‐Tarng Jou Taiwan

Maria Caterina Putti Italy

Michael R. Grunwald

850 ×1.0

HEMAT

220 ×0.4

457 ×1.2

GENET

204 ×0.9

ONCOL

387 ×2.3

PHEOH

Citations per year, relative to Michael R. Grunwald Michael R. Grunwald (= 1×) peers Maria Caterina Putti

Countries citing papers authored by Michael R. Grunwald

Since Specialization

Citations

This map shows the geographic impact of Michael R. Grunwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Grunwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Grunwald more than expected).

Fields of papers citing papers by Michael R. Grunwald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Grunwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Grunwald. The network helps show where Michael R. Grunwald may publish in the future.

Co-authorship network of co-authors of Michael R. Grunwald

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Grunwald. A scholar is included among the top collaborators of Michael R. Grunwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Grunwald. Michael R. Grunwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Mei‐Jie, Rizwan Romee, Navneet S. Majhail, et al.. (2025). Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Transplantation and Cellular Therapy. 31(3). 174.e1–174.e12.

Arnall, Justin, et al.. (2024). Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 31(2). 111.e1–111.e10. 2 indexed citations

Boselli, Danielle, Issam S. Hamadeh, Nikolai A. Podoltsev, et al.. (2024). Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice. Annals of Hematology. 103(8). 2837–2843.

Bhave, Rupali, Ruben A. Mesa, & Michael R. Grunwald. (2023). Top advances of the year: Myeloproliferative neoplasms. Cancer. 129(23). 3685–3691.

Knight, Thomas G., Danielle Boselli, Jing Ai, et al.. (2023). Enhanced Support Services Including Nurse Navigation Mitigate Socioeconomic Disparities in the Treatment of Patients with Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 5078–5078. 1 indexed citations

Knight, Thomas G., Myra Robinson, Jing Ai, et al.. (2022). Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic Malignancy. JCO Oncology Practice. 18(9). e1494–e1504. 43 indexed citations

Prébet, Thomas, Aaron D. Goldberg, Joseph G. Jurcic, et al.. (2022). A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leukemia & lymphoma. 63(9). 2180–2188. 6 indexed citations

O’Donnell, Paul V., Claudio G. Brunstein, Ephraim J. Fuchs, et al.. (2021). Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes. Transplantation and Cellular Therapy. 28(2). 109.e1–109.e8. 10 indexed citations

Abedin, Sameem, Mark A. Schroeder, Rizwan Romee, et al.. (2021). Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis. British Journal of Haematology. 195(3). 429–432. 10 indexed citations

10.

Kunte, Siddharth, Lisa Rybicki, Auro Viswabandya, et al.. (2021). Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study. Leukemia. 36(3). 856–864. 20 indexed citations

11.

Zwicker, Jeffrey I., et al.. (2021). Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study. Haematologica. 107(5). 1106–1110. 10 indexed citations

12.

Milne, Paul, Charlotte S. Wilhelm-Benartzi, Michael R. Grunwald, et al.. (2019). Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia. Blood Advances. 3(20). 3052–3061. 17 indexed citations

13.

Knight, Thomas G., Myra Robinson, Michael R. Grunwald, et al.. (2018). Patient Reported Financial Toxicity in Acute Leukemia. Blood. 132(Supplement 1). 4796–4796. 9 indexed citations

14.

Copelan, Edward A., et al.. (2017). Recent advances in hematopoietic cell transplantation in myelodysplastic syndrome.. PubMed. 24(130). 51–57. 1 indexed citations

15.

Grunwald, Michael R., John M. Burke, David J. Kuter, et al.. (2017). Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis from the Reveal Study. Blood. 130. 2924. 1 indexed citations

16.

Grunwald, Michael R., Danielle Boselli, Lauren Bohannon, et al.. (2017). Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia. Blood. 130. 3864–3864. 2 indexed citations

17.

Patel, Jai N., Issam S. Hamadeh, Qing Zhang, et al.. (2017). Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation. Blood. 130. 3215–3215. 1 indexed citations

18.

Lipford, Edward H., et al.. (2016). Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype. Hematology/Oncology and Stem Cell Therapy. 10(1). 35–38. 6 indexed citations

19.

Copelan, Edward A., Michael R. Grunwald, Lawrence J. Druhan, & Belinda R. Avalos. (2015). Use of molecular markers to determine postremission treatment in acute myeloid leukemia with normal cytogenetics. Hematology/Oncology and Stem Cell Therapy. 8(4). 143–149. 2 indexed citations

20.

Prabhakaran, Vivek, Michael R. Grunwald, J. Kent Werner, et al.. (2004). Localization of cognitive processes using Stroke patients and fMRI. eScholarship (California Digital Library). 26(26). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact